Cetera Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
Cetera Investment Advisers's HQL Position: Q2 2026 in Review
Cetera Investment Advisers opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 11,227 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #4399 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in HQL as recently as Q3 2024.
Cetera Investment Advisers first reported a position in HQL in Q4 2020 and has held it in 17 quarters since. The position peaked at $2.9M in Q2 2021. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- Cetera Investment Advisers held 11,227 shares of abrdn Life Sciences Investors worth $225K as of Q2 2026.
- abrdn Life Sciences Investors was a new Cetera Investment Advisers position in Q2 2026.
- abrdn Life Sciences Investors made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4399 holding.
- Cetera Investment Advisers first reported a position in abrdn Life Sciences Investors in Q4 2020 and has held it in 17 quarters since.
- Cetera Investment Advisers's abrdn Life Sciences Investors position peaked at $2.9M in Q2 2021.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.